Current Status of the Matson Evaluation of Drug Side Effects (MEDS)

Autor/inn/en	Matson, Johnny L.; Cervantes, Paige E.
Titel	Current Status of the Matson Evaluation of Drug Side Effects (MEDS)
Quelle	In: Research in Developmental Disabilities: A Multidisciplinary Journal, 34 (2013) 5, S.1849-1853 (5 Seiten)Infoseite zur Zeitschrift PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	0891-4222
DOI	10.1016/j.ridd.2013.02.030
Schlagwörter	Risk; Psychometrics; Mental Retardation; Drug Therapy; Symptoms (Individual Disorders); Test Validity; Test Reliability; Interaction; Mental Disorders + Suchen Sie Ihr Suchwort? Risiko; Psychometry; Psychometrie; Geistige Behinderung; Psychiatrische Symptomatik; Testvalidität; Testreliabilität; Interaktion; Mental illness; Geisteskrankheit
Abstract	The Matson Evaluation of Drug Side Effects (MEDS) is currently the best established and most researched measure of drug side effects in the intellectual disability (ID) literature. Initial research was conducted on its psychometric properties such as reliability and validity. More recent research studies have used the measure to determine the interactive effects of severity of drug side effects on adaptive and social behaviors as well as symptoms of commonly medicated psychiatric conditions among persons with ID. Most recently the MEDS has been used to study potential risk factors of psychotropic drugs. The present study was written to review the current status of MEDS research in the broader context of psychotropic drug side effect research in general. (As Provided).
Anmerkungen	Elsevier. 3251 Riverport Lane, Maryland Heights, MO 63043. Tel: 800-325-4177; Tel: 314-447-8000; Fax: 314-447-8033; e-mail: JournalCustomerService-usa@elsevier.com; Web site: http://www.elsevier.com
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2017/4/10